Fluoride Varnish for Treatment of White Spot Lesions
Launched by SOLVENTUM US LLC · Dec 27, 2011
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
To determine the efficacy of 5% sodium fluoride varnish with tricalcium phosphate in reverting white spot lesions after fixed orthodontic treatment, compared with a fluoride gel.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • no systemic disease
- • has completed fixed orthodontic treatment, brackets debonded
- • has at least two teeth with whitre spot lesions
- • has received conventional periodontal therapy after orthodontic tretament
- Exclusion Criteria:
- • presence of enamel hypoplasia or dental fluorosis
- • presence of tetracycline pigmentation
- • periodontal pocketing of 3mm or greater
- • taking antibiotics
- • presence of carious cavities
- • allergy to fluoride gel / varnish being used in study
About Solventum Us Llc
Solventum US LLC is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions through rigorous research and development. With a commitment to improving patient outcomes, the company specializes in conducting high-quality clinical trials across various therapeutic areas, leveraging cutting-edge technology and methodologies. Solventum US LLC collaborates with leading healthcare professionals and institutions to ensure the highest standards of safety and efficacy in its studies, ultimately aiming to bring transformative treatments to market. Through its strategic approach and emphasis on scientific integrity, Solventum US LLC plays a vital role in the evolution of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
Franklin Garcia-Godoy, DDS, MS
Principal Investigator
University of Tennessee
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials